in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lubrizol introduces a new pharmaceutical excipient
7:59 AM MDT | June 4, 2014 | Deepti Ramesh
Lubrizol says that its life science polymers business has introduced a new pharmaceutical-grade excipient, Pathway. As pharmaceutical companies face the challenge of the patent cliff, the development of new routes of administration for existing drug products is an important potential strategy these companies can use to maintain the success of their product franchises. Pathway excipients help drug manufacturers achieve their goals of developing these novel, controlled-release drug products, Lubrizol says. With the implementation of the GMP-quality system at...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee